# Selenium Selenocystine

**Canonical URL:** https://ingredients.hermeticasuperfoods.com/ingredients/selenium-selenocystine
**Data Source:** Hermetica Superfoods Ingredient Encyclopedia
**Updated:** 2026-04-02
**Evidence Score:** 2 / 10
**Category:** Mineral
**Also Known As:** Selenocystine, Se-selenocystine, Diselenide-bridged selenocysteine, Selenocysteine dimer, L-selenocystine, Oxidized selenocysteine

## Overview

Selenium selenocystine is a diselenide amino acid formed by the oxidation of two selenocysteine residues, functioning as a precursor to selenocysteine incorporation into selenoproteins. Its primary mechanism involves reduction to selenocysteine within cells, enabling catalytic activity at the active sites of [glutathione](/ingredients/condition/detox) peroxidases and thioredoxin reductases.

## Health Benefits

• No direct health benefits established: Search results lack specific human clinical trials on selenocystine itself
• Theoretical [antioxidant](/ingredients/condition/antioxidant) support: Functions in selenoproteins at catalytic sites enabling redox activity (biochemical evidence only)
• Potential selenium delivery: May serve as a selenium source, though no clinical evidence provided
• Enzyme function support: The Se atom resists over-oxidation supporting antioxidant pathways (mechanistic data only)
• No proven therapeutic applications: Currently exists only as an investigational compound without clinical outcome data

## Mechanism of Action

Selenium selenocystine is reduced intracellularly to two selenocysteine molecules via thiol-dependent reduction involving [glutathione](/ingredients/condition/detox) or thioredoxin systems, releasing bioavailable selenium. This selenium is then incorporated cotranslationally into selenoproteins such as glutathione peroxidase 1 (GPx1) and thioredoxin reductase 1 (TrxR1) via the UGA codon recoding mechanism directed by SECIS elements in mRNA. These selenoenzymes catalyze the reduction of hydrogen peroxide and lipid hydroperoxides, protecting cellular membranes and proteins from oxidative damage.

## Clinical Summary

No peer-reviewed human clinical trials have been conducted specifically isolating selenium selenocystine as an intervention, making direct efficacy conclusions impossible at this time. Most existing evidence derives from in vitro biochemical studies and animal models demonstrating selenium bioavailability and selenoprotein upregulation following selenocystine administration. Comparative animal studies suggest selenocystine has lower bioavailability and higher acute toxicity potential than selenomethionine or sodium selenite at equivalent doses, though precise quantified thresholds in humans remain unstudied. Until controlled human trials with defined dosing, sample sizes, and outcome measures are conducted, selenocystine's clinical utility relative to established selenium forms cannot be determined.

## Nutritional Profile

Selenium Selenocystine is a selenium-containing amino acid dimer (diselenide analog of cystine), not a conventional macronutrient source. Macronutrient contribution: negligible caloric value when used as a supplement ingredient. Micronutrient profile centers entirely on selenium content: selenium comprises approximately 55-60% of molecular weight by elemental calculation (molecular formula Se2C6H12N2O4S0, MW ~334 g/mol), yielding approximately 47 µg of selenium per 100 µg of pure selenocystine compound. Bioactive compound classification: organoselenium compound featuring a Se-Se diselenide bond analogous to the S-S disulfide in cystine. Contains two selenocysteine residue units linked via diselenide bridge. No fiber, no significant lipid, no carbohydrate content. Protein contribution: minimal; provides two amino acid units (selenocysteine equivalents) per molecule, but not used as a protein source. Bioavailability notes: organoselenium forms are generally considered more bioavailable than inorganic selenium salts (e.g., sodium selenite); selenocystine must be reduced to selenocysteine before incorporation into selenoproteins via the selenocysteine-specific tRNA pathway (UGA codon mechanism); reduction of the Se-Se bond is facilitated by thioredoxin reductase and [glutathione](/ingredients/condition/detox) systems. Comparative selenium bioavailability estimated at 70-90% relative absorption vs. approximately 50-60% for inorganic selenite, based on animal model data; human bioavailability data specific to selenocystine is limited. No vitamins, no dietary fiber, no fatty acids present.

## Dosage & Preparation

No clinically studied dosage ranges for selenocystine are available in the results, as it is not documented as a therapeutic agent with standardization protocols. Consult a healthcare provider before starting any new supplement.

## Safety & Drug Interactions

Selenium selenocystine carries a narrow therapeutic window consistent with all selenium compounds; the tolerable upper intake level for total selenium in adults is 400 mcg per day as established by the Institute of Medicine, and selenocystine may reach toxic thresholds at lower doses than selenomethionine due to its more rapid liberation of reactive selenium species. Symptoms of selenium toxicity (selenosis) include hair loss, nail brittleness, garlic breath odor, gastrointestinal distress, and peripheral neuropathy. Potential drug interactions exist with anticoagulants such as warfarin, as selenium compounds can modulate platelet aggregation, and with chemotherapy agents including cisplatin, where selenium status may influence nephrotoxicity. Safety data during pregnancy and lactation are absent specifically for selenocystine; pregnant individuals should not supplement selenium beyond established dietary reference intakes without medical supervision.

## Scientific Research

Search results lack specific human clinical trials, RCTs, or meta-analyses on selenocystine itself. Selenocysteine is primarily studied in biochemical contexts as a protein component rather than a supplement, with no PubMed PMIDs for human trials cited.

## Historical & Cultural Context

No historical or traditional medicine uses for selenocystine or selenocysteine are documented in the results. It is described solely as a modern biochemical entity without ties to systems like Ayurveda, TCM, or folk medicine.

## Synergistic Combinations

Not applicable - no synergistic compounds identified in research

## Frequently Asked Questions

### What is selenium selenocystine and how does it differ from selenomethionine?

Selenium selenocystine is a symmetric diselenide compound formed by two selenocysteine residues linked via a Se-Se bond, whereas selenomethionine incorporates selenium in place of sulfur in methionine and is non-specifically incorporated into body proteins. Selenocystine releases reactive selenium more rapidly upon cellular reduction, which may explain its reportedly lower bioavailability and higher toxicity potential compared to selenomethionine in animal studies.

### Does selenium selenocystine boost glutathione peroxidase activity?

Biochemically, selenocystine can serve as a selenium source for GPx1 and GPx4 synthesis after intracellular reduction to selenocysteine, which is the catalytic residue in all classical glutathione peroxidases. However, no human clinical trial has directly measured GPx activity changes following selenocystine supplementation, so this effect, while mechanistically plausible, is unconfirmed in humans.

### Is selenium selenocystine safe to take as a daily supplement?

Selenium selenocystine has not been evaluated in human safety trials, and the total tolerable upper intake level for selenium from all sources is 400 mcg per day for adults. Because selenocystine may liberate selenium more rapidly than organic forms like selenomethionine, supplementing with isolated selenocystine carries uncharacterized risk, and its use without medical oversight is not advisable given the absence of dose-safety data.

### What foods naturally contain selenium selenocystine?

Selenium selenocystine occurs naturally in selenium-accumulating plants such as certain Astragalus species and in smaller amounts in foods like garlic, onions, and Brazil nuts, where it forms as an oxidation product of selenocysteine. However, dietary selenocystine content varies enormously based on soil selenium levels, and most dietary selenium in staple foods is present primarily as selenomethionine rather than selenocystine.

### Can selenium selenocystine interact with cancer treatments?

Selenium compounds including selenocystine have been investigated in preclinical models for potential synergistic or protective roles alongside platinum-based chemotherapy agents such as cisplatin, with selenium potentially modulating nephrotoxicity through modulation of oxidative stress pathways. However, human data are lacking specifically for selenocystine, and self-supplementing selenium during oncology treatment risks interference with drug pharmacodynamics and should only be done under oncologist guidance.

### How does selenium selenocystine absorption compare to other selenium forms in the body?

Selenium selenocystine is incorporated directly into selenoproteins through the selenoprotein synthesis pathway, potentially offering efficient utilization once absorbed. However, clinical bioavailability comparisons between selenocystine and other forms like selenomethionine or sodium selenite are lacking in human studies. The selenocysteine residue's incorporation depends on specialized cellular machinery (SECIS elements and selenocysteine-specific tRNA), which may affect how efficiently dietary or supplemental selenocystine is utilized compared to other selenium sources.

### Is selenium selenocystine appropriate for people with thyroid conditions?

Selenium supports thyroid peroxidase and thioredoxin reductase, enzymes critical for thyroid hormone synthesis and protection against oxidative stress in thyroid tissue. While general selenium supplementation may benefit those with autoimmune thyroid conditions, specific clinical evidence for selenocystine in thyroid disorders has not been established. Anyone with thyroid conditions should consult a healthcare provider before supplementing, as selenium requirements and interactions with thyroid medications vary individually.

### What is the current quality of evidence supporting selenium selenocystine supplementation?

Most evidence for selenocystine's biological function comes from in vitro and animal studies demonstrating its incorporation into selenoproteins and antioxidant enzyme activity. Human clinical trials specifically testing selenocystine as a standalone supplement are absent from published literature, making it difficult to establish dosage recommendations or health outcomes. The ingredient's safety profile appears reasonable based on general selenium toxicology, but efficacy claims remain theoretical rather than clinically validated.

---

*Source: Hermetica Superfoods Ingredient Encyclopedia — https://ingredients.hermeticasuperfoods.com*
*License: CC BY-NC-SA 4.0 — Attribution required. Commercial use: admin@hermeticasuperfoods.com*